AKTX · Categories · Form 4

AKTX - SEC Form 4 insider transactions

Akari Therapeutics plc (AKTX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for AKTX

• 79d
  SEC Form 4 filed by Director Neal James R

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 166d
  SEC Form 4 filed by Director Prudo-Chlebosz Raymond

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 166d
  SEC Form 4 filed by Director Patel Sandip I

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 166d
  SEC Form 4 filed by Director Huh Hoyoung

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 166d
  SEC Form 4 filed by Interim CFO Farag Kameel D.

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 166d
  SEC Form 4 filed by Director Patel Samir Rashmikant

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 166d
  SEC Form 4 filed by Director Bazemore Robert B

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 166d
  SEC Form 4 filed by CEO Gaslightwala Abizer

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 211d
  Interim CFO Farag Kameel D. was granted 58,619 units of American Depositary Shares representing Ordinary Shares (SEC Form 4)

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 222d
  Interim CFO Farag Kameel D. was granted 6,277 units of American Depositary Shares representing Ordinary Shares (SEC Form 4)

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 352d
  CEO Gaslightwala Abizer was granted 45,000 units of American Depositary Shares representing Ordinary Shares, increasing direct ownership by 22% to 246,428 units (SEC Form 4)

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 356d
  CEO Gaslightwala Abizer was granted 20,000 units of American Depositary Shares representing Ordinary Shares, increasing direct ownership by 11% to 201,428 units (SEC Form 4)

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 400d
  Director Patel Sandip I was granted 44,642 units of American Depositary Shares representing Ordinary Shares, increasing direct ownership by 10% to 496,499 units (SEC Form 4)

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 436d
  SEC Form 4 filed by Director Bazemore Robert B

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 436d
  SEC Form 4 filed by Director Neal James R

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 436d
  SEC Form 4 filed by Director Patel Sandip I

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 436d
  SEC Form 4 filed by Director Prudo-Chlebosz Raymond

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 436d
  SEC Form 4 filed by Director Patel Samir Rashmikant

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 436d
  SEC Form 4 filed by Director Gaslightwala Abizer

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 436d
  SEC Form 4 filed by CFO Hombeck Torsten

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 436d
  SEC Form 4 filed by Director Huh Hoyoung

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 450d
  Director Huh Hoyoung was granted 892,857 units of American Depositary Shares representing Ordinary Shares, increasing direct ownership by 23% to 4,695,854 units (SEC Form 4)

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 450d
  Director Prudo-Chlebosz Raymond was granted 446,428 units of American Depositary Shares representing Ordinary Shares, increasing direct ownership by 22% to 2,484,990 units (SEC Form 4)

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 450d
  Director Patel Samir Rashmikant was granted 406,250 units of American Depositary Shares representing Ordinary Shares (SEC Form 4)

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 450d
  Director Bazemore Robert B was granted 44,642 units of American Depositary Shares representing Ordinary Shares (SEC Form 4)

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 450d
  Director Neal James R was granted 4,464 units of American Depositary Shares representing Ordinary Shares, increasing direct ownership by 14% to 36,271 units (SEC Form 4)

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 450d
  Director Gaslightwala Abizer was granted 133,928 units of American Depositary Shares representing Ordinary Shares, increasing direct ownership by 282% to 181,428 units (SEC Form 4)

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 481d
  Amendment: Director Gaslightwala Abizer was granted 11,640 units of American Depository Shares representing Ordinary Shares, increasing direct ownership by 32% to 47,500 units (SEC Form 4)

  4/A - Akari Therapeutics Plc (0001541157) (Issuer)
• 506d
  Director Gaslightwala Abizer was granted 11,439 units of American Depository Shares representing Ordinary Shares, increasing direct ownership by 47% to 35,860 units (SEC Form 4)

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 506d
  CFO Hombeck Torsten was granted 200 units of American Depository Shares representing Ordinary Shares (SEC Form 4)

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 508d
  Director Neal James R was granted 8,000,000 units of Ordinary Shares, increasing direct ownership by 33% to 32,216,000 units (SEC Form 4)

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 512d
  Director Gaslightwala Abizer was granted 1,720,000 units of Ordinary Shares, increasing direct ownership by 2% to 71,720,000 units (SEC Form 4)

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 512d
  Director Patel Samir Rashmikant was granted 208,000 units of Ordinary Shares (SEC Form 4)

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 520d
  Director Patel Samir Rashmikant was granted 3,600,000 units of Ordinary Shares (SEC Form 4)

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 520d
  Director Gaslightwala Abizer was granted 40,000,000 units of Ordinary Shares, increasing direct ownership by 133% to 70,000,000 units (SEC Form 4)

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 523d
  Director Gaslightwala Abizer was granted 30,000,000 units of Ordinary Shares (SEC Form 4)

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 523d
  Director Patel Samir Rashmikant was granted 7,500,000 units of Ordinary Shares (SEC Form 4)

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 524d
  Director Patel Samir Rashmikant was granted 1,400,000 units of Ordinary Shares (SEC Form 4)

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 524d
  Director Patel Samir Rashmikant was granted 1,400,000 units of Ordinary Shares (SEC Form 4)

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 524d
  Director Neal James R was granted 2,000,000 units of Ordinary Shares, increasing direct ownership by 9% to 24,216,000 units (SEC Form 4)

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 546d
  Director Patel Samir Rashmikant was granted 419,286,000 units of Ordinary Shares (SEC Form 4)

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 546d
  Director Prudo-Chlebosz Raymond was granted 419,286,000 units of Ordinary Shares, increasing direct ownership by 11% to 4,077,124,600 units (SEC Form 4)

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 561d
  Director Patel Samir Rashmikant was granted 1,404,622,000 units of Ordinary Shares (SEC Form 4)

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 579d
  SEC Form 4 filed by Director Patel Samir Rashmikant

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 608d
  SEC Form 4 filed by Director Patel Samir Rashmikant

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 623d
  SEC Form 4 filed by Director Bazemore Robert B

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 701d
  SEC Form 4 filed by Director Grissinger Michael

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 701d
  SEC Form 4 filed by Director Williams Donald A

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 701d
  SEC Form 4 filed by Director Hashad Mohamed Wa'El Ahmed

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 701d
  SEC Form 4 filed by Director Prudo-Chlebosz Raymond

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 701d
  Director Patel Samir Rashmikant was granted 91,396,000 units of Ordinary Shares (SEC Form 4)

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 729d
  Patel Samir Rashmikant was granted 1,326,258,000 units of Ordinary Shares (SEC Form 4)

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 729d
  Prudo-Chlebosz Raymond was granted 1,326,258,000 units of Ordinary Shares, increasing direct ownership by 57% to 3,657,838,600 units (SEC Form 4)

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 761d
  Dicicco Wendy F was granted 158,473,915 units of Ordinary Shares (SEC Form 4)

  4 - Akari Therapeutics Plc (0001541157) (Issuer)
• 763d
  Jacques Rachelle Suzanne was granted 479,569,892 units of Ordinary Shares, increasing direct ownership by 89% to 1,018,027,792 units (SEC Form 4)

  4 - Akari Therapeutics Plc (0001541157) (Issuer)

Other AKTX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends